Companies / BGT

BIO-GENE TECHNOLOGY LTD

ASX:BGTMaterials
438.1M shares on issueASX (delayed) · snapshot 28 Oct 2026617.4M fully diluted+40.9% if every option and right converts$0.013price · delayed$7.4MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 71.0% of what they think they own, once every option and right converts.

Very high
Dilution risk

Share count grew 67% in 24 months; runway 2–4 quarters; 5 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway3.2 quarters of funding
Share-count growth (24m)67.2%measured to the latest Appendix 2A, not to the share count above
Raise cadence (24m)5 cash raises
Options & rights overhang40.9% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

BIO-GENE TECHNOLOGY LTD's ordinary share count increased 67.2% between May 2025 and August 2026, its latest share-count filing, to 438M shares. The company completed 5 capital raises in the 24-month window, totalling A$9.5M, the most recent being a placement with SPP in May 2026 raising A$3.3M. Options and rights on issue could convert into 179M new shares, representing a 40.9% overhang of the current share count, with none in the money; the nearest expiry is October 2027. The company has 2 to 4 quarters of funding at the recent spend rate as of its June 2026 quarter. One proposed securities issue (Appendix 3B) is pending with an expected issue date in December 2026.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 3

Is BGT raising capital?

Bio-Gene Technology has 1 proposed issue of securities pending under Appendix 3B as at 28 Oct 2026; the most recent raise announced is Placement (with SPP) of $3.3M on 26 May 2026.

How much cash does BGT have?

In its quarterly cash report for the quarter ended 30 June 2026, Bio-Gene Technology reported $1.9M of cash and estimated 3.1 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do BGT's options expire?

Unexercised options and rights equal 40.9% of Bio-Gene Technology's shares on issue; the nearest expiry is Oct 2027.

Get told when this changes
Get BGT alerts
Free for up to 2 companies. A daily email when BGT raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
40.9%
Options & rights overhang
0.0%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
1
Raises · last 12 months
3.2 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 438.1M per ASX (delayed) (snapshot 28 Oct 2026).
200M300M400MDec 24Nov 25Oct 26Cash raise · 26 May 2026Cash raise · 21 July 2025Cash raise · 5 May 2025Cash raise · 5 May 2025Cash raise · 21 July 2025438.1M

Cash runway

3.2 qtrs OURS
Two to four quarters of funding at the recent spend rate.
Funds operations to about Aug 2027 at the reported spend rate.
$2.5M cash after burn.
FILED 3.1 qtrs · $1.9M cash · quarter ended 30 June 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.FILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
15 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
10 Aug 20262A · quoted issueBGT : ORDINARY FULLY PAID388.1MAppendix 2A
10 Aug 20262A · quoted issueBGT : ORDINARY FULLY PAID420.8MAppendix 2A
10 Aug 20262A · quoted issueBGT : ORDINARY FULLY PAID401.3MAppendix 2A
10 Aug 20263G · unquotedBGT : ORDINARY FULLY PAID386.1MAppendix 3G
24 June 20262A · quoted issueBGT : ORDINARY FULLY PAID386.1MAppendix 2A

Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (388.1M) need not equal the current count above (438.1M).

Free account
14 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Capital raises

5 cash raises in the last 24 months · 1 in the last 12 months

every 6.3 monthsaverage gap between raises
5.1 monthssince the most recent
5 May 2025 – 26 May 2026first to most recent in this window
$3.3M
Placement (with SPP)
At 2.5c, 13.8% below the last close
26 May 2026 COMPLETE
Free account
6 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
4 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

No estimate — the filings already exceed 15% of the share count we can measure, which means securities were added to the base during the year, or holders ratified an issue, in a way we cannot match. The company has also placed under the additional 10% (Listing Rule 7.1A), which is not counted in this figure.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
1 pending issue on record — Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Unlocks on a paid plan
See plans

Options & convertible securities

40.9%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
179.3M
Potential new shares
Oct 2027
Nearest expiry
What a price move would switch on
89.6M179.3M$0.013 now0.25× today ($0.003) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.006) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.010) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.013) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.016) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.019) — 0 of the priced supply in the money, 0.0% of shares on issue2× today ($0.026) — 0 of the priced supply in the money, 0.0% of shares on issue3× today ($0.039) — 124.3M of the priced supply in the money, 28.4% of shares on issue5× today ($0.065) — 179.3M of the priced supply in the money, 40.9% of shares on issue10× today ($0.130) — 179.3M of the priced supply in the money, 40.9% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.013 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 3× today’s price, which takes it to 124.3M (28.4% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
CodeSecurityTypeExercise priceExpiryOn issueSource
—OptionsPrice-triggered$0.03515 Oct 202769.2MFiling
BGTANOptionsPrice-triggered$0.03415 May 202855.0MFiling
BGTAMOptionsPrice-triggered$0.04615 May 203055.0MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

Free account
3 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
10 Aug 2026Andrew GuthrieBuy placement200k100k—$5k3Y notice
10 Aug 2026Christopher RamseyBuy placement200k100k—$5k3Y notice
10 Aug 2026Peter MayBuy placement200k100k—$5k3Y notice
10 Aug 2026Timothy GroganBuy placement200k100k—$5k3Y notice
Free account
8 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock BGT freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

28 Oct 2026Proposed issue of securities - BGT
19 Oct 2026Bio-Gene Receives $343,000 R&D Tax Incentive
12 Oct 2026Date of 2026 Annual General Meeting
7 Oct 2026Flavocide efficacy results against deer ticks published
28 Aug 2026Corporate Governance Statement
28 Aug 2026Appendix 4G
28 Aug 2026$PAppendix 4E and 2026 Annual Report
27 Aug 2026Change in substantial holding
27 Aug 2026Change in substantial holding
10 Aug 2026Notification regarding unquoted securities - BGT
10 Aug 2026Change of Director's Interest Notice x 4
10 Aug 2026Placement Completed and Cleansing Notice
10 Aug 2026Application for quotation of securities - BGT
10 Aug 2026Application for quotation of securities - BGT
10 Aug 2026Application for quotation of securities - BGT
5 Aug 2026Results of Meeting
31 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
6 July 2026Notice of Extraordinary General Meeting/Proxy Form
24 June 2026Result of Security Purchase Plan
24 June 2026Application for quotation of securities - BGT

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.